JP2024536224A5 - - Google Patents

Info

Publication number
JP2024536224A5
JP2024536224A5 JP2024519594A JP2024519594A JP2024536224A5 JP 2024536224 A5 JP2024536224 A5 JP 2024536224A5 JP 2024519594 A JP2024519594 A JP 2024519594A JP 2024519594 A JP2024519594 A JP 2024519594A JP 2024536224 A5 JP2024536224 A5 JP 2024536224A5
Authority
JP
Japan
Prior art keywords
independently
compound according
alkyl
linker
following structure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024519594A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024536224A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/059148 external-priority patent/WO2023052970A1/en
Publication of JP2024536224A publication Critical patent/JP2024536224A/ja
Publication of JP2024536224A5 publication Critical patent/JP2024536224A5/ja
Pending legal-status Critical Current

Links

JP2024519594A 2021-09-30 2022-09-27 がん処置用のピロロベンゾジアゼピンコンジュゲート Pending JP2024536224A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163250931P 2021-09-30 2021-09-30
US63/250,931 2021-09-30
PCT/IB2022/059148 WO2023052970A1 (en) 2021-09-30 2022-09-27 Pyrrolobenzodiazepine conjugates for cancer treatment

Publications (2)

Publication Number Publication Date
JP2024536224A JP2024536224A (ja) 2024-10-04
JP2024536224A5 true JP2024536224A5 (https=) 2025-09-30

Family

ID=83688787

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024519594A Pending JP2024536224A (ja) 2021-09-30 2022-09-27 がん処置用のピロロベンゾジアゼピンコンジュゲート

Country Status (6)

Country Link
US (1) US20250009898A1 (https=)
EP (1) EP4408477A1 (https=)
JP (1) JP2024536224A (https=)
KR (1) KR20240062140A (https=)
CN (1) CN118043082A (https=)
WO (1) WO2023052970A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017240154B2 (en) 2016-04-01 2021-08-12 Sony Group Corporation Ultra bright dimeric or polymeric dyes
WO2017177065A2 (en) 2016-04-06 2017-10-12 Sony Corporation Ultra bright dimeric or polymeric dyes with spacing linker groups
US12539334B2 (en) 2018-01-12 2026-02-03 Sony Group Corporation Phosphoalkyl polymers comprising biologically active agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111757757A (zh) * 2017-12-21 2020-10-09 梅尔莎纳医疗公司 吡咯并苯并二氮呯抗体共轭物
JP7580689B2 (ja) * 2018-06-27 2024-11-12 ソニーグループ株式会社 デオキシリボースを含むリンカー基を有するポリマー色素
JP7650819B2 (ja) * 2019-04-24 2025-03-25 ブイオーアール バイオファーマ インコーポレーテッド 抗-cd45抗体薬物コンジュゲート及びその使用

Similar Documents

Publication Publication Date Title
JP2024536224A5 (https=)
JP2022526014A5 (https=)
JP2022526651A5 (https=)
JP2022526017A5 (https=)
JP2021520423A5 (https=)
JP2021529194A5 (https=)
JP2024537069A5 (https=)
ES2761949T3 (es) Haptenos, conjugados de haptenos, composiciones de los mismos y método para su preparación y uso
JP2021510696A5 (https=)
JP2019516821A5 (https=)
JP2021518410A5 (https=)
CN114072178A (zh) 可编程的聚合药物
EP3952917A1 (en) Programmable polymeric drugs
EP0800831A1 (en) Diagnostic marker
JP2018515628A5 (https=)
JP2019516812A5 (https=)
JP2023552448A5 (https=)
HUT59129A (en) Method for producing azocyclic compounds
JP2023550791A5 (https=)
JP3669752B2 (ja) 診断用マーカー
US20250009786A1 (en) Automated synthesis of polymeric dual drugs
EP4408477A1 (en) Pyrrolobenzodiazepine conjugates for cancer treatment
Wang et al. Thiazole orange–Spermine conjugate: A potent human telomerase inhibitor comparable to BRACO-19
US20260056191A1 (en) Polymers and conjugates comprising the same
Malan et al. Fluorescent ligands for the histamine H2 receptor: synthesis and preliminary characterization